These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 37975152)
1. A novel nomogram based on body composition and nutritional indicators to predict the prognosis of patients with muscle-invasive bladder cancer undergoing radical cystectomy. Zhong X; Pan Y; Wu K; Wang L; Dou P; Tan P; Zhang P; Li X Cancer Med; 2023 Dec; 12(24):21627-21638. PubMed ID: 37975152 [TBL] [Abstract][Full Text] [Related]
2. Prognostic nutritional index combined with NLR to construct a survival prediction model and decision analysis of patients with muscle-invasive bladder cancer after surgery. Wang J; Shi H; Fan Z; Yang J; Zheng Y; Zeng D; Zhang J; Hai B Cancer Med; 2023 Jul; 12(13):14207-14224. PubMed ID: 37199384 [TBL] [Abstract][Full Text] [Related]
3. Nomogram of Combining CT-Based Body Composition Analyses and Prognostic Inflammation Score: Prediction of Survival in Advanced Epithelial Ovarian Cancer Patients. Wang X; Zhang C; Cao F; Wang CB; Dong JN; Wang ZH Acad Radiol; 2022 Sep; 29(9):1394-1403. PubMed ID: 34955366 [TBL] [Abstract][Full Text] [Related]
4. Nomogram Based on Body Composition and Prognostic Nutritional Index Predicts Survival After Curative Resection of Gastric Cancer. Tao C; Hong W; Yin P; Wu S; Fan L; Lei Z; Yu Y Acad Radiol; 2024 May; 31(5):1940-1949. PubMed ID: 37981487 [TBL] [Abstract][Full Text] [Related]
5. [Establishment and verification of a prognostic nomogram for survival of tongue squamous cell carcinoma patients who underwent cervical dissection]. Su J; Wang X; Sun Z Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Feb; 56(1):120-130. PubMed ID: 38318906 [TBL] [Abstract][Full Text] [Related]
6. Development and Internal Validation of a Nomogram Predicting Overall Survival Based on Log ODDS of Positive Lymph-Nodes for Post Radical Cystectomy Patients in Muscle Invasive Carcinoma of Bladder. Patel KN; Salunke A; Sharma M; Puj K; Rathod P; Warikoo V; Bakshi G; Pandya SJ Clin Genitourin Cancer; 2023 Jun; 21(3):e153-e165. PubMed ID: 36549982 [TBL] [Abstract][Full Text] [Related]
7. A Prognostic Nomogram Based on Log Odds of Positive Lymph Nodes to Predict Overall Survival for Non-Metastatic Bladder Cancer Patients after Radical Cystectomy. Yang J; Huang H; Li W; Ran S; Hu J; Zhang Y; Li W; Chen C; He W Curr Oncol; 2022 Sep; 29(10):6834-6846. PubMed ID: 36290816 [TBL] [Abstract][Full Text] [Related]
8. A CT-based deep learning model predicts overall survival in patients with muscle invasive bladder cancer after radical cystectomy: a multicenter retrospective cohort study. Wei Z; Xv Y; Liu H; Li Y; Yin S; Xie Y; Chen Y; Lv F; Jiang Q; Li F; Xiao M Int J Surg; 2024 May; 110(5):2922-2932. PubMed ID: 38349205 [TBL] [Abstract][Full Text] [Related]
9. Development and validation of a prognostic nomogram for predicting cancer-specific survival after radical cystectomy in patients with bladder cancer:A population-based study. Yang Z; Bai Y; Liu M; Hu X; Han P Cancer Med; 2020 Dec; 9(24):9303-9314. PubMed ID: 33063464 [TBL] [Abstract][Full Text] [Related]
10. A Novel Nutrition-Based Nomogram to Predict Prognosis After Curative Resection of Gastric Cancer. Zheng H; Zhu W; Niu Z; Li H; Zheng Y; Liu Z; Yao J; Lou H; Hu H; Gong L; Pan H; Pan Q Front Nutr; 2021; 8():664620. PubMed ID: 34760907 [No Abstract] [Full Text] [Related]
11. Association of preoperative muscle-adipose index measured by computed tomography with survival in patients with esophageal squamous cell carcinoma. Qian D; Shen P; Zhu J; Ji S; Kong Y World J Surg Oncol; 2024 Feb; 22(1):61. PubMed ID: 38383431 [TBL] [Abstract][Full Text] [Related]
12. Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium. Mir MC; Marchioni M; Zargar H; Zargar-Shoshtari K; Fairey AS; Mertens LS; Dinney CP; Krabbe LM; Cookson MS; Jacobsen NE; Griffin J; Montgomery JS; Vasdev N; Yu EY; Xylinas E; McGrath JS; Kassouf W; Dall'Era MA; Sridhar SS; Aning J; Shariat SF; Wright JL; Thorpe AC; Morgan TM; Holzbeierlein JM; Bivalacqua TJ; North S; Barocas DA; Lotan Y; Grivas P; Stephenson AJ; Shah JB; van Rhijn BW; Spiess PE; Daneshmand D; Black PC Eur Urol Focus; 2021 Nov; 7(6):1347-1354. PubMed ID: 32771446 [TBL] [Abstract][Full Text] [Related]
13. Population-based outcome of muscle-invasive bladder cancer following radical cystectomy: who can benefit from adjuvant chemotherapy? Tian J; Sun J; Fu G; Xu Z; Chen X; Shi Y; Jin B Transl Androl Urol; 2021 Jan; 10(1):356-373. PubMed ID: 33532324 [TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of the Systemic Inflammatory Response Index in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Population-Based Study. Ni J; Wang K; Zhang H; Xie J; Xie J; Tian C; Zhang Y; Li W; Su B; Liang C; Song X; Peng B Front Oncol; 2021; 11():722151. PubMed ID: 34485155 [TBL] [Abstract][Full Text] [Related]
15. Nomogram based on baseline clinicopathological characteristics for predicting bladder cancer-specific survival to neoadjuvant chemotherapy in muscle-invasive bladder cancer. Font A; Domenech M; Buisan O; Lopez H; González A; Etxaniz O; Matas M; Elias X; Gomez M; Figols M; Horneros J; Pardo JC; Notario L; Ruiz de Porras V; Perez I; Areal J; Esteve A World J Urol; 2022 Nov; 40(11):2627-2634. PubMed ID: 36107212 [TBL] [Abstract][Full Text] [Related]
16. Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making. Aziz A; Shariat SF; Roghmann F; Brookman-May S; Stief CG; Rink M; Chun FK; Fisch M; Novotny V; Froehner M; Wirth MP; Schnabel MJ; Fritsche HM; Burger M; Pycha A; Brisuda A; Babjuk M; Vallo S; Haferkamp A; Roigas J; Noldus J; Stredele R; Volkmer B; Bastian PJ; Xylinas E; May M BJU Int; 2016 Feb; 117(2):272-9. PubMed ID: 25381844 [TBL] [Abstract][Full Text] [Related]
17. Development and validation of a novel nomogram model for predicting the survival of patients with T2-4a, N0-x, M0 bladder cancer: a retrospective cohort study. Xia Y; Liu X; Ma B; Huang T; Xu D; Zhao C Am J Clin Exp Urol; 2023; 11(6):500-515. PubMed ID: 38148935 [TBL] [Abstract][Full Text] [Related]
18. [Establishment and validation of a novel nomogram to predict overall survival after radical nephrectomy]. Xiong LB; Zou XP; Ning K; Luo X; Peng YL; Zhou ZH; Wang J; Li Z; Yu CP; Dong P; Guo SJ; Han H; Zhou FJ; Zhang ZL Zhonghua Zhong Liu Za Zhi; 2023 Aug; 45(8):681-689. PubMed ID: 37580273 [No Abstract] [Full Text] [Related]
19. Modeling 1-year Relapse-free Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients with Clinical T2-4N0M0 Urothelial Bladder Carcinoma: Endpoints for Phase 2 Trials. Bandini M; Briganti A; Plimack ER; Niegisch G; Yu EY; Bamias A; Agarwal N; Sridhar SS; Sternberg CN; Vaishampayan U; Théodore C; Rosenberg JE; Bellmunt J; Galsky MD; Montorsi F; Necchi A Eur Urol Oncol; 2019 May; 2(3):248-256. PubMed ID: 31200838 [TBL] [Abstract][Full Text] [Related]
20. A Nomogram Including Sarcopenia for Predicting Progression-Free Survival in Patients with Localized Papillary Renal Cell Carcinoma: A Retrospective Cohort Study. Su W; Wu Y; Liao S; Zhang Z; Zhang Y; Ou W; Yu J; Xiang F; Luo C; Zheng F Ann Surg Oncol; 2024 Sep; 31(9):5815-5826. PubMed ID: 38954088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]